| Literature DB >> 34351669 |
Hagar Nofal1, Rania AlAkad1, Ahmad Nofal1, Eman Rabie2,3, Thithiwat Chaikul4, Frank Po-Chao Chiu4, Rashida Pramanik4, Ahmad Alabdulkareem4, Alexandros Onoufriadis4.
Abstract
H syndrome is a rare autosomal recessive disorder with clinical features comprising: Hyperpigmentation, Hypertrichosis, Hearing loss, Heart anomalies, low Height, Hypogonadism and Hepatosplenomegaly. H syndrome results from loss-of-function mutations in SLC29A3 which leads to abnormal proliferation and function of histiocytes. Herein, we discuss the considerable phenotypic heterogeneity detected in a consanguineous Egyptian family comprising of 4 affected siblings, two of which are monozygotic twin and the possible therapeutics. The phenotypic variability may be attributed to the role of histiocytes in the tissue response to injury. Such variable expressivity of H syndrome renders the diagnosis challenging and delays the management. The different treatment approaches used for this rare entity are reviewed. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.Entities:
Keywords: H syndrome; Histiocytosis; SLC29A3; hyperpigmentation; hypertrichosis; sclerosis
Year: 2021 PMID: 34351669 DOI: 10.1111/dth.15082
Source DB: PubMed Journal: Dermatol Ther ISSN: 1396-0296 Impact factor: 2.851